Taj Worldwide | Taj Group | Media | Career | FAQs | Feedback | contact us
 
Taj Logo
especially Products
 
Quality Medicines Api Generic Manufacturing For Doctors Brands Newsroom
 

cetrilin-a-A ® Taj Products

 
HOME >> PRODUCTS >> Taj Products >> cetrilin-a-A
Taj  ALL Products View Products According to Category

cetrilin.bmp


Comsition
LevoCetirizine Dihydrochloride......................................5 mg
Pseudoephedrine.......................................................30 mg
Ambroxol..................................................................60 mg

Levocetirizines a third-generation non-sedative antihistamine, developed from the second-generation antihistamine cetirizine. Chemically, levocetirizine is the active enantiomer of cetirizine. It is the L-enantiomer of the cetirizine racemate. Levocetirizine works by blocking histamine receptors. It does not prevent the actual release of histamine from mast cells, but prevents it binding to its receptors. This in turn prevents the release of other allergy chemicals and increased blood supply to the area, and provides relief from the typical symptoms of heigh fever.

healthy people

Indications
cetrilin-a-A is indicated in the treatment of perennial and seasonal allergic rhinitis pruritus, allergic asthma, allergic conjunctivitis and urticaria.

Description
An antihistamine is a drug serves to reduce or eliminate effects. which serves to reduce or eliminate effects mediated by histamine. an endogenous chemical mediator released during allergic reactions. Only agents where the main therapeutic effect is mediated by negative modulation of histamine receptors are termed antihistamines - other agents may have antihistaminergic action but are not true antihistamines.In common use, the term antihistamine refers only to H1-receptor antagonists, also known as H1-antihistamines.

Dosage and Administration
Adults and Children 12 yr of age and older

2.5 to 5 mg once daily in the evening (max, 5 mg once daily).
Children 6 to 11 yr of age

2.5 mg (˝ tablet or 1 teason oral solution) once daily in the evening (max, 2.5 mg once daily).
Dose Adjustment for Renal Function Impairment
Adults and Children 12 yr of age and older


Mild renal function impairment
Recommended dosage is 2.5 mg once daily.
Moderate renal function impairment

Recommended dosage is 2.5 mg once every other day.
Severe renal function impairment
Recommended dosage is 2.5 mg twice weekly, separated by 3 to 4 days.

Indications and Usage

Relief of symptoms associated with allergic rhinitis; treatment of uncomplicated skin manifestations of chronic idiopathic urticaria.
Contraindications

Patients with end-stage renal disease and patients undergoing hemodialysis; children 6 to 11 yr of age with renal function impairment; hypersensitivity to any comnent of the product or to certirizine.

Presentations
10 tablets

 

Note : This product information is intended only for residents of the India. Taj Pharmaceuticals Limited,  medicines help to treat and prevent a range of conditions—from the most common to the most challenging—for people around the world.

Information for Health Care Professionals

*** Please consult local Prescribing Information for any product before use. This website is an international information resource for healthcare professionals with an interest in disease management. This website is not intended to replace the advice of a qualified healthcare professional. Above brand is a trademark of the Taj group of companies (Taj Pharmaceuticals Limited).



 



Allergy Free for Life


 









 

 

 







 

 

 

 

 

 



 

              
 Print page   Send by mail


 

 

 

 

 

 



 

   
   
PRODUCTS
 
 
   
   
   
  india flag
  The Taj Pharmaceuticals Limited (Taj Group) has operations in every major international market
    AFRICA
  ASIA PACIFIC
  EUROPE
  MIDDLE EAST
  THAILAND
  BANGLADESH
  NORTH AMERICA
  SOUTH AMERICA
  RUSSIA
  NEWZELAND
  UNITED KINGDOM
 

  ASTHAMATIC

 

 

 

 

 

 

 

 

 


 

 

 

 
 www.tajpharma.com

   

 

About Taj

Company

Products Diseases Health Divisions Media R & D Sustainability
Figure & Rerts Investors

Countries

Brochure E-mail us Exrt & Imrt
Vacancies | C & F Agency | Distributor | Group Companies | History | Enquire Form | Countries | Pharma Technology
 Contact | Sitemap | User Terms and Conditions | Privacy and Cookie Statement